You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 1 - 25 of 3,060
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Biospecimen Acquisition for Myelodysplastic Syndromes

Recruiting
  • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Relapsed / Refractory MDS Trial (NCR300)

    Not yet recruiting
    • Relapsed / Refractory Myelodysplastic Syndromes
    • (no location specified)
    May 7, 2022

    Interplay Between Immune and Metabolic Programs in

    Recruiting
    • Myelodysplastic Syndromes
      • Toulouse, France
        IUCT-Oncopole University Hospital
      May 17, 2022

      Low Risk MDS Trial (R906289 Monosodium (R289 Na))

      Not yet recruiting
      • Low Risk Myelodysplastic Syndromes
      • R906289 Monosodium (R289 Na)
      • (no location specified)
      Jul 22, 2022

      MDS Trial (Decitabine/Cedazuridine, Magrolimab)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • (no location specified)
      Apr 18, 2023

      Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Inpatient serious illness care program
      • Rochester, New York
        University of Rochester
      Jun 21, 2022

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022

      Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • Myelodysplastic Syndromes
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 28, 2022

      Mean Platelet Volume and Its Relation to Risk Stratification of

      Completed
      • Myelodysplastic Syndromes
        • (no location specified)
        Jan 21, 2022

        Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • Rochester, Minnesota
        • +1 more
        Feb 15, 2023

        High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

        Recruiting
        • High Grade Myelodysplastic Syndromes
        • Aurora, Colorado
          Universtiy of Colorado Denver
        Nov 17, 2022

        MDS Trial (AG-946, Placebo)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • (no location specified)
        Aug 4, 2022

        MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

        Recruiting
        • Myelodysplastic Syndromes
        • +5 more
        • description of MDS pzatient cohort
        • Brest, France
          Chu Brest
        Oct 27, 2022

        MDS Trial in Saint Louis (vosaroxin, Azacitidine)

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Saint Louis, Missouri
          Washington University School of Medicine
        Mar 23, 2022

        Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

        Recruiting
        • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
        • TQB2618 injection azacitidine, AZA decitabine, DAC
        • ChengDu, Sichuan, China
          West China Hospital of Sichuan University
        Jun 16, 2022

        Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

        Recruiting
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +2 more
        • VEN+AZA+Modified BUCY
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Apr 10, 2023

        Leukemias, MDS Trial in Houston (sapacitabine)

        Completed
        • Leukemias
        • Myelodysplastic Syndromes
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        Dec 7, 2021

        MDS Trial in New York (selinexor (KPT-330))

        Completed
        Has Results
        • Myelodysplastic Syndromes
        • selinexor (KPT-330)
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Feb 11, 2022

        MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 2, 2022

        MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

        Recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • Tampa, Florida
          Moffitt Cancer Center
        Feb 16, 2023

        Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

        Recruiting
        • Chronic Myelomonocytic Leukemia
        • +5 more
        • Canakinumab
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 7, 2022

        MDS Trial in New Haven (CPX-351)

        Withdrawn
        • MDS
        • New Haven, Connecticut
          Yale University; Smilow Cancer Center
        Jan 6, 2022

        MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • (no location specified)
        Nov 29, 2021

        Strategy for High-Risk Myelodysplastic Syndromes in Patients

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Allogeneic Stem Cell Transplantation
        • Agen, France
        • +9 more
        Jul 5, 2022